Patents by Inventor Jayesh Mehta

Jayesh Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID BIOPSY YIELD ENHANCEMENT
    Publication number: 20240151725
    Abstract: Provided herein are methods, kits, systems, and compositions or liquid biopsy yield enhancement.
    Type: Application
    Filed: December 8, 2023
    Publication date: May 9, 2024
    Inventors: Seema Singhal, Jayesh Mehta, Neil Mehta, Aran Mehta
  • LIQUID BIOPSY YIELD ENHANCEMENT
    Publication number: 20240103011
    Abstract: Provided herein are methods, kits, systems, and compositions or liquid biopsy yield enhancement.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 28, 2024
    Inventors: Seema Singhal, Jayesh Mehta, Neil Mehta, Aran Mehta
  • Liquid biopsy yield enhancement
    Patent number: 11933783
    Abstract: Provided herein are methods, kits, systems, and compositions or liquid biopsy yield enhancement.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: March 19, 2024
    Inventors: Seema Singhal, Jayesh Mehta, Neil Mehta, Aran Mehta
  • LIQUID BIOPSY YIELD ENHANCEMENT
    Publication number: 20210263032
    Abstract: Provided herein are methods, kits, systems, and compositions or liquid biopsy yield enhancement.
    Type: Application
    Filed: July 20, 2020
    Publication date: August 26, 2021
    Inventors: Seema Singhal, Jayesh Mehta, Neil Mehta, Aran Mehta
  • Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
    Patent number: 8524655
    Abstract: The present invention relates to the use of stem cell factor (SCF) polypeptide, alone and in combination with granulocyte colony stimulating factor (G-CSF) polypeptide, in the prevention or treatment of injury to the brain after cerebral ischemia or neurological disorder. More particularly, the invention provides methods of improving neurological function and outcome after stroke by the administration of SCF polypeptide, alone and in combination with G-CSF polypeptide. This treatment can be used alone or in combination with other well-known methods of treatment of cerebral ischemia and neurological disorders in a mammal.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: September 3, 2013
    Assignee: Northwestern University
    Inventors: Li-Ru Zhao, John Kessler, Seema Singhal, Jayesh Mehta
  • Use of SCF and G-CSF in the Treatment of Cerebral Ischemia and Neurological Disorders
    Publication number: 20100286039
    Abstract: The present invention relates to the use of stem cell factor (SCF) polypeptide, alone and in combination with granulocyte colony stimulating factor (G-CSF) polypeptide, in the prevention or treatment of injury to the brain after cerebral ischemia or neurological disorder. More particularly, the invention provides methods of improving neurological function and outcome after stroke by the administration of SCF polypeptide, alone and in combination with G-CSF polypeptide. This treatment can be used alone or in combination with other well-known methods of treatment of cerebral ischemia and neurological disorders in a mammal.
    Type: Application
    Filed: February 26, 2010
    Publication date: November 11, 2010
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Li-Ru Zhao, John Kessler, Seema Singhal, Jayesh Mehta
  • Home Healthcare Documentation Clearing House
    Publication number: 20090083073
    Abstract: A system and method for handling communications, including care plan oversight, between medical providers, home healthcare providers and others using a central clearing house to link the respective parties together.
    Type: Application
    Filed: September 26, 2008
    Publication date: March 26, 2009
    Inventors: Jayesh Mehta, Seema Singhal
  • G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
    Publication number: 20070258945
    Abstract: The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.
    Type: Application
    Filed: April 5, 2007
    Publication date: November 8, 2007
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Jayesh Mehta, Seema Singhal, Charles Davidson, Nirat Beohar, Robert Bonow
  • G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
    Patent number: 7220407
    Abstract: The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: May 22, 2007
    Assignee: Amgen Inc.
    Inventors: Jayesh Mehta, Seema Singhal, Charles Davidson, Nirat Beohar, Robert Bonow
  • G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
    Publication number: 20050089507
    Abstract: The present invention relates to methods of using Granulocyte Colony Stimulating Factor (G-CSF) polypeptide in conjunction with reperfusion therapy in the treatment of acute myocardial infarction or other ischemic events. This treatment can be used alone or in combination with other well-known methods of treatment.
    Type: Application
    Filed: October 27, 2003
    Publication date: April 28, 2005
    Inventors: Jayesh Mehta, Seema Singhal, Charles Davidson, Nirat Beohar, Robert Bonow